Atara Biotherapeutics, Inc. (LON:0HIY)

Atara Biotherapeutics Statistics

Total Valuation

LON:0HIY has a market cap or net worth of GBP 79.95 million. The enterprise value is 82.36 million.

Market Cap	79.95M
Enterprise Value	82.36M

Important Dates

The next estimated earnings date is Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	7.21M
Shares Outstanding	n/a
Shares Change (YoY)	+102.28%
Shares Change (QoQ)	+10.19%
Owned by Insiders (%)	2.63%
Owned by Institutions (%)	29.13%
Float	4.15M

Valuation Ratios

The trailing PE ratio is 4.59 and the forward PE ratio is 8.93.

PE Ratio	4.59
Forward PE	8.93
PS Ratio	0.71
PB Ratio	-2.93
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.06, with an EV/FCF ratio of -1.59.

EV / Earnings	4.73
EV / Sales	0.73
EV / EBITDA	2.06
EV / EBIT	2.60
EV / FCF	-1.59

Financial Position

The company has a current ratio of 1.02

Current Ratio	1.02
Quick Ratio	0.87
Debt / Equity	n/a
Debt / EBITDA	0.31
Debt / FCF	-0.24
Interest Coverage	10.90

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	30.86%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	352.48%
Revenue Per Employee	2.97M
Profits Per Employee	458,130
Employee Count	153
Asset Turnover	1.76
Inventory Turnover	n/a

Taxes

In the past 12 months, LON:0HIY has paid 8,927 in taxes.

Income Tax	8,927
Effective Tax Rate	0.05%

Stock Price Statistics

The stock price has decreased by -18.35% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-18.35%
50-Day Moving Average	14.94
200-Day Moving Average	11.16
Relative Strength Index (RSI)	43.82
Average Volume (20 Days)	2,403

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.23

Income Statement

In the last 12 months, LON:0HIY had revenue of GBP 113.03 million and earned 17.41 million in profits. Earnings per share was 1.46.

Revenue	113.03M
Gross Profit	52.85M
Operating Income	31.76M
Pretax Income	17.42M
Net Income	17.41M
EBITDA	33.37M
EBIT	31.76M
Earnings Per Share (EPS)	1.46

Balance Sheet

The company has 10.20 million in cash and 12.62 million in debt, with a net cash position of -2.41 million.

Cash & Cash Equivalents	10.20M
Total Debt	12.62M
Net Cash	-2.41M
Net Cash Per Share	n/a
Equity (Book Value)	-27.25M
Book Value Per Share	-3.78
Working Capital	278,978

Cash Flow

In the last 12 months, operating cash flow was -51.86 million and capital expenditures -66,955, giving a free cash flow of -51.93 million.

Operating Cash Flow	-51.86M
Capital Expenditures	-66,955
Free Cash Flow	-51.93M
FCF Per Share	n/a

Margins

Gross margin is 46.76%, with operating and profit margins of 28.10% and 15.40%.

Gross Margin	46.76%
Operating Margin	28.10%
Pretax Margin	15.41%
Profit Margin	15.40%
EBITDA Margin	29.52%
EBIT Margin	28.10%
FCF Margin	n/a

Dividends & Yields

LON:0HIY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-102.28%
Shareholder Yield	-102.28%
Earnings Yield	21.77%
FCF Yield	-64.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 20, 2024. It was a reverse split with a ratio of 0.04.

Last Split Date	Jun 20, 2024
Split Type	Reverse
Split Ratio	0.04

Scores

LON:0HIY has an Altman Z-Score of -83.42 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-83.42
Piotroski F-Score	5